Copyright Reports & Markets. All rights reserved.

Global Small Interfering RNA (siRNA) Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Liposome Based Systemic Therapy
      • 1.4.3 Nanoparticle Based Systemic Therapy
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Research Institutions
      • 1.5.4 Pharmaceutical and Biotechnology Companies
      • 1.5.5 Academic Institutions
      • 1.5.6 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Small Interfering RNA (siRNA) Therapeutics Market Size
    • 2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
      • 2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Small Interfering RNA (siRNA) Therapeutics Market Size by by Players
      • 3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Small Interfering RNA (siRNA) Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 5.2 Small Interfering RNA (siRNA) Therapeutics Key Players in North America
    • 5.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 5.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 6.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Europe
    • 6.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 6.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    7 China

    • 7.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 7.2 Small Interfering RNA (siRNA) Therapeutics Key Players in China
    • 7.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 7.4 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 8.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Japan
    • 8.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 8.4 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 9.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 9.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    10 India

    • 10.1 India Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 10.2 Small Interfering RNA (siRNA) Therapeutics Key Players in India
    • 10.3 India Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 10.4 India Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
    • 11.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
    • 11.4 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 GE
      • 12.1.1 GE Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019))
      • 12.1.5 GE Recent Development
    • 12.2 Horizon Discovery
      • 12.2.1 Horizon Discovery Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.2.5 Horizon Discovery Recent Development
    • 12.3 Thermo Scientific
      • 12.3.1 Thermo Scientific Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.3.5 Thermo Scientific Recent Development
    • 12.4 OPKO Health
      • 12.4.1 OPKO Health Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.4.5 OPKO Health Recent Development
    • 12.5 AInylam Pharmaceuticals
      • 12.5.1 AInylam Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.5.5 AInylam Pharmaceuticals Recent Development
    • 12.6 Arrowhead Research
      • 12.6.1 Arrowhead Research Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.6.5 Arrowhead Research Recent Development
    • 12.7 Sanofi Genzyme
      • 12.7.1 Sanofi Genzyme Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.7.5 Sanofi Genzyme Recent Development
    • 12.8 Genecon Biotechnologies
      • 12.8.1 Genecon Biotechnologies Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.8.5 Genecon Biotechnologies Recent Development
    • 12.9 Arbutus Biopharma
      • 12.9.1 Arbutus Biopharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.9.5 Arbutus Biopharma Recent Development
    • 12.10 Silent Therapeutics
      • 12.10.1 Silent Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Small Interfering RNA (siRNA) Therapeutics Introduction
      • 12.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
      • 12.10.5 Silent Therapeutics Recent Development
    • 12.11 Sylentis

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Small Interfering RNA (siRNA) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Interfering RNA (siRNA) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      GE
      Horizon Discovery
      Thermo Scientific
      OPKO Health
      AInylam Pharmaceuticals
      Arrowhead Research
      Sanofi Genzyme
      Genecon Biotechnologies
      Arbutus Biopharma
      Silent Therapeutics
      Sylentis

      Market segment by Type, the product can be split into
      Liposome Based Systemic Therapy
      Nanoparticle Based Systemic Therapy
      Other

      Market segment by Application, split into
      Hospital
      Research Institutions
      Pharmaceutical and Biotechnology Companies
      Academic Institutions
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Small Interfering RNA (siRNA) Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Small Interfering RNA (siRNA) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Small Interfering RNA (siRNA) Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now